A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors
NCT01853306
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
71
Enrollment
INDUSTRY
Sponsor class
Conditions
Oncology
BRCA Mutated
High Grade Serous Ovarian Cancer
BRCA Mutated Breast Cancer
Interventions
DRUG:
Veliparib
Sponsor
AbbVie